OTC Plan B Would Not Boost Barr's Sales Before Mid-Year, CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr expects little financial contribution from over-the-counter Plan B before July even if the OTC switch is approved by the Jan. 21 user fee deadline